Breast Cancer Index and prediction of benefit from extended endocrine therapy in breast cancer patients treated in the Adjuvant Tamoxifen—To Offer More? (aTTom) trial

著者: John M.S. Bartlett, Dennis C. Sgroi, Kai Treuner, Y. Zhang, Ikhlaaq Ahmed, Tammy Piper, Ranelle Salunga, Elena F. Brachtel, Sarah Pirrie, Catherine A. Schnabel, Daniel Rea - Annals of Oncology 2019 被引用: 206